Virtual Seminar: Targeting PIK3CA Mutant Cancers
Zhenghe J. Wang, Ph.D.
Dale H. Cowan and Ruth Goodman Blum Professor of Cancer Research
Department of Genetics and Genome Sciences
Comprehensive Care Center
Case Western Reserve University
Virtual Pioneers in Biomedical Research Seminar: Targeting PIK3CA Mutant Cancers
March 11, 2022
11:00 a.m. to 12:00 p.m.
About this Seminar
PIK3CA is the most frequently mutated oncogene in human cancers. Dr. Wang will present two projects that translate bench discoveries made in his laboratory into clinical trials to treat PIK3CA mutant colorectal cancer patients. The first approach targets glutamine addiction of PIK3CA mutant colorectal cancer, whereas the second approach combines drugs that target epigenetics and PI3K alpha.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home Item
How Fluid Flow Shapes the Brain: Cancer and Cognitive Function , homeOct. 30, 2025, 5:30 p.m. (Reception at 5 p.m.) | Jennifer Munson, Ph.D., Professor and Director, Cancer Research Center — Roanoke, Fralin Biomedical Research Institute; Professor, Department of Biomedical Engineering and Mechanics, Virginia Tech College of Engineering | Maury Strauss Distinguished Public Lecture
-
Home Item
Thinking the Right Thoughts , homeOct. 31, 2025, 11 a.m. | Nathaniel Daw, Ph.D., Professor, Computational and Theoretical Neuroscience, Department of Psychology, Princeton University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
-
Home Item
Pandemics — The Lessons I've Learned , homeNov. 6, 2025, 5:30 p.m. (Reception at 5 p.m.) | Teresa Lambe, Ph.D., OBE, Calleva Head of Vaccine Immunology, Professor of Vaccinology and Immunology, University of Oxford | Maury Strauss Distinguished Public Lecture
-
Home Item
Understanding Vascular Morphogenesis and Morphology: Live Insights from Zebrafish , homeNov. 21, 2025, 11:00 a.m. | Arndt F. Siekmann, Ph.D., Associate Professor, Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania | Co-Sponsored by the Center for Vascular and Heart Research, Fralin Biomedical Research Institute
-
Home Item
The Metabolic Switch in Development and Degeneration , homeDec. 12, 2025, 11:00 a.m. | Elizabeth Jonas, M.D., Harvey and Kate Cushing Professor of Internal Medicine (Endocrinology), Yale School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home Item
Innovative Strategies for Overcoming Challenges in Brain Tumor Treatment , homeJan. 16, 2026, 11:00 a.m. | Kristin Huntoon, Ph.D., D.O., Assistant Professor, Department of Neurosurgery, University of Arizona | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke